Loading company…
Tissium SA, based in Paris, makes biomorphic programmable polymers for tissue reconstruction in surgical procedures.
Founded in 2013 and headquartered in Paris, France, Tissium SA develops biomorphic programmable polymers for reconstructing damaged tissue in surgery, including peripheral nerve, cardiovascular and gastrointestinal applications. Christophe Bancel is CEO and Maria Pereira is CIO. In June 2026 the company raised EUR 30 million in venture debt from the European Investment Bank, part of a larger EUR 60 million equity and debt funding round. It is at the Series D stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in